Implantable Heart Pump Controller Synchronization

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current implantable left ventricular assist devices (LVADs) with rotary pumps provide durable support but compromise on physiological flow, leading to complications such as gastrointestinal bleeding, aortic incompetence, and limited cardiac unloading due to non-physiologic pulseless continuous blood flow, which affects patient quality of life and increases medical costs.

Innovation Solution

An implantable ventricular assist device controller that synchronizes physiological flow with the cardiac cycle, using an ultra-compact microcontroller connected to a heart pump, capable of wireless communication and power transfer, to adjust pump speed based on EKG signals, enabling pulsatile flow that mimics natural heart function.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If rotary pumps with single moving part are used, then durability is improved, but physiological flow is compromised leading to pulseless continuous blood flow

Engineering Contradiction:
ImprovedurabilityVSAvoidnon-physiologic pulseless blood flow
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent applies periodic action by implementing a pulsatile flow pattern through the rotary pump. The controller modulates the pump operation to create periodic flow variations that mimic natural cardiac pulsations, transforming the continuous non-physiologic flow into a pulsatile physiologic flow while maintaining the durability benefits of the rotary pump design

Inventive Principle:
Principle #19Periodic action

2Ease of operation

If transcutaneous driveline is used for power and control, then pump operation is enabled, but driveline-associated infections occur

Engineering Contradiction:
Improvepump operationVSAvoiddriveline-associated infections
Core Design Contradiction:
Ease of operationVSObject-affected harmful factors

Solution Approach 1:

The patent extracts the harmful transcutaneous driveline from the system by implementing wireless power and control technologies. The pump is powered inductively through electromagnetic coupling and controlled via wireless communication, completely eliminating the percutaneous connection that serves as an infection pathway while maintaining full operational capability

Inventive Principle:
Principle #2Taking out (Extraction)

3Device complexity

If continuous flow is provided, then pump simplicity is maintained, but cardiac unloading is limited and gastrointestinal bleeding increases

Engineering Contradiction:
Improvepump simplicityVSAvoidgastrointestinal bleeding and limited cardiac unloading
Core Design Contradiction:
Device complexityVSObject-generated harmful factors

Solution Approach 1:

The patent applies dynamics by making the pump flow characteristics variable rather than fixed. The controller dynamically adjusts the pump speed and flow pattern in response to physiological conditions, enabling the system to switch between continuous and pulsatile flow modes, and adjust cardiac unloading levels to prevent gastrointestinal bleeding while maintaining operational simplicity

Inventive Principle:
Principle #15Dynamics

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The controller improves patient outcomes by reducing complications, enhancing cardiac recovery, and increasing the efficiency of blood flow, achieving a 17.54% to 35.49% improvement in flow rate and power efficiency compared to existing systems, while minimizing driveline-related infections and improving quality of life.

Implementation Method 1

The controller further comprises a receiver resonator for wireless energy transfer

Methodology Applied
Scientific EffectWireless energy transfer: Electromagnetic Induction

Data Source

PatentUS9919088B2Implantable heart pump controller
Publication Date: 2018.03.20 UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION
  • US9919088B2 patent drawing
  • US9919088B2 patent drawing
  • US9919088B2 patent drawing

AI summary

The present invention provides devices, systems, and methods for control of ventricular assist devices. The invention includes an implantable controller that is operatively programmed to direct physiological flow through a ventricular assist device that is substantially synchronized to the cardiac cycle of the subject. The implantable controller is also communicatively connected to an external control unit, such that the implantable controller can transmit data to the external control unit, and instructions can be sent from the external control unit to the implantable controller.